<!DOCTYPE html>
<html>
  <head>
    <title>Thyroid dysfunction</title>
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <meta charset="utf-8">
    <!-- Bootstrap -->
    <link href="//netdna.bootstrapcdn.com/bootswatch/3.2.0/flatly/bootstrap.min.css" rel="stylesheet" media="screen">
    <link href="/css/site.css" rel="stylesheet" media="screen">
    <link href="/css/syntax.css" rel="stylesheet" media="screen">

    <!-- HTML5 Shim and Respond.js IE8 support of HTML5 elements and media queries -->
    <!-- WARNING: Respond.js doesn't work if you view the page via file:// -->
    <!--[if lt IE 9]>
      <script src="https://oss.maxcdn.com/libs/html5shiv/3.7.0/html5shiv.js"></script>
      <script src="https://oss.maxcdn.com/libs/respond.js/1.3.0/respond.min.js"></script>
    <![endif]-->
<script>
  (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
  (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
  m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
  })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

  ga('create', 'UA-48968311-4', 'jandecaluwe.com');
  ga('send', 'pageview');

</script>
  </head>

  <body>

    <!-- Fixed navbar -->
    <div class="navbar navbar-default navbar-fixed-top">
      <div class="container">
        <div class="navbar-header">
          <button type="button" class="navbar-toggle" data-toggle="collapse" data-target=".navbar-collapse">
            <span class="icon-bar"></span>
            <span class="icon-bar"></span>
            <span class="icon-bar"></span>
          </button>
          <a class="navbar-brand" href="/">Rory’s notes</a>
        </div>
        <div class="navbar-collapse collapse">

          <ul class="nav navbar-nav navbar-left">
 
          </ul>

          <ul class="nav navbar-nav navbar-right">
            <li class="active"><a href="/notes/">notes</a></li>
          </ul>

        </div><!--/.nav-collapse -->
      </div>
    </div>


<div class="container">

  <ol class="breadcrumb">
    <li><a href="/">Home</a></li>
      <li><a href="/notes/">notes</a></li>
      <li><a href="/notes/endocrine/">endocrine</a></li>
      <li class="active">Thyroid dysfunction</li>
  </ol>

  <div class="page-header">
 
    <h1>Thyroid dysfunction</h1>
  </div>

  <div class="row">

    <div class="col-md-3" role="navigation"> 
 
      <div class="sidebar" data-spy="affix" data-offset-top="80" data-offset-bottom="60">
        <div class="well">
          <a href="#"><strong>Thyroid dysfunction</strong></a>
          <div class="toc">
<ul>
<li><a href="#hypothyroidism">Hypothyroidism</a><ul>
<li><a href="#suspicion">suspicion</a></li>
<li><a href="#risk-factors">risk factors</a></li>
<li><a href="#thyroid-antibodies">Thyroid antibodies</a></li>
<li><a href="#primary-hypothyroidism">Primary hypothyroidism</a><ul>
<li><a href="#treatment">Treatment</a></li>
<li><a href="#referal">Referal</a></li>
</ul>
</li>
<li><a href="#subclinical-hypothyroidism">Subclinical hypothyroidism</a><ul>
<li><a href="#treatment_1">Treatment</a></li>
</ul>
</li>
</ul>
</li>
<li><a href="#hyperthyroidism">Hyperthyroidism</a><ul>
<li><a href="#suspicion_1">suspicion</a></li>
<li><a href="#overt-hyperthryoidism">Overt hyperthryoidism</a><ul>
<li><a href="#treatment_2">Treatment</a></li>
</ul>
</li>
<li><a href="#subclincial-hyperthroidism">Subclincial hyperthroidism</a></li>
</ul>
</li>
<li><a href="#pregnancy">Pregnancy</a><ul>
<li><a href="#hypothryoidism">Hypothryoidism</a></li>
<li><a href="#hyperthyroidism_1">Hyperthyroidism</a></li>
</ul>
</li>
<li><a href="#drugs">drugs</a><ul>
<li><a href="#amiodarone">Amiodarone</a></li>
<li><a href="#lithium">Lithium</a></li>
</ul>
</li>
</ul>
</div>

        </div>
      </div>
    </div>
 
    <div class="content">
      <div class="col-md-6" role="main">
        <blockquote>
<p>5% women</p>
<p>1% men</p>
<p>lack of evidence to support routine screening in asymptomatic people</p>
<p>TSH = initial test</p>
</blockquote>
<h3 id="hypothyroidism">Hypothyroidism</h3>
<h4 id="suspicion">suspicion</h4>
<ul>
<li>
<p>high</p>
<ul>
<li>
<p>goitre</p>
</li>
<li>
<p>delayed reflexes</p>
</li>
</ul>
</li>
<li>
<p>intermediate</p>
<ul>
<li>
<p>fatigue</p>
</li>
<li>
<p>weight gain/difficulty losing weight</p>
</li>
<li>
<p>cold intolerance</p>
</li>
<li>
<p>dry, rough, pale skin</p>
</li>
<li>
<p>consitpation</p>
</li>
<li>
<p>facial swelling (oedema)</p>
</li>
<li>
<p>hoarseness</p>
</li>
</ul>
</li>
<li>
<p>Low </p>
<ul>
<li>
<p>coarse dry hair</p>
</li>
<li>
<p>hair loss</p>
</li>
<li>
<p>muscle cramps/aches</p>
</li>
<li>
<p>depression</p>
</li>
<li>
<p>irritability</p>
</li>
<li>
<p>memory loss</p>
</li>
<li>
<p>abnormal menstrual cycles</p>
</li>
<li>
<p>decreased libido</p>
</li>
</ul>
</li>
</ul>
<h4 id="risk-factors">risk factors</h4>
<ul>
<li>
<p>autoimmune disease</p>
<ul>
<li>
<p>t1 DM</p>
</li>
<li>
<p>addison’s disease</p>
</li>
<li>
<p>coeliac disease</p>
</li>
</ul>
</li>
<li>
<p>genetic conditions</p>
<ul>
<li>
<p>Down</p>
</li>
<li>
<p>Turner</p>
</li>
</ul>
</li>
<li>
<p>treatment with radioactive iodine therapy or surgery for hyperthyroidism</p>
</li>
<li>
<p>radiotherapy to neck</p>
</li>
<li>
<p>history of post partum thyroiditis</p>
</li>
</ul>
<blockquote>
<p>consider screening every 1-2 years or if symtoms/signs</p>
</blockquote>
<h4 id="thyroid-antibodies">Thyroid antibodies</h4>
<ul>
<li>
<p>TPO-Ab</p>
<ul>
<li>
<p>anti-thyroglobulin antibodies</p>
</li>
<li>
<p>risk factor for autoimmune throid disorders</p>
</li>
<li>
<p>all with autoimmune hypothyroidism and up to 80% Graves disease have TPO antibodies</p>
<ul>
<li>usually at high levels</li>
</ul>
</li>
</ul>
</li>
</ul>
<h4 id="primary-hypothyroidism">Primary hypothyroidism</h4>
<ul>
<li>
<p>increased TSH and decreased FT4</p>
<ul>
<li>
<p>untreated</p>
<ul>
<li>
<p>fatigue</p>
</li>
<li>
<p>weight gain</p>
</li>
<li>
<p>abnormal lipid profile</p>
</li>
<li>
<p>heart failure</p>
</li>
<li>
<p>children: retard growth and mental development</p>
</li>
<li>
<p>myxodedema coma = rare complication</p>
</li>
</ul>
</li>
<li>
<p>autoimmune thyroid disease: Hashimoto’s throiditis/atrophic thyroiditis</p>
</li>
<li>
<p>consider iodine deficiency</p>
</li>
</ul>
</li>
</ul>
<h5 id="treatment">Treatment</h5>
<ul>
<li>
<p>Replacement for symptomatic with TSH >10</p>
<ul>
<li>
<p>lower threshold to treat young woman especially if may become pregnant</p>
</li>
<li>
<p>2nd TSH to confirm diagnosis</p>
</li>
</ul>
</li>
<li>
<p>Levothyroxine</p>
<ul>
<li>
<p>1.6mck.kg.day</p>
</li>
<li>
<p>young adults start full dose</p>
</li>
<li>
<p>elderly start 12.5-25mcg/day and inc every 6 weeks</p>
<ul>
<li>long term bradycardia may mask coronary artery disease</li>
</ul>
</li>
<li>
<p>symptoms generally improve within 2–3 weeks</p>
</li>
<li>
<p>months before patient feels bakc to N health after biochemical correction of TSH</p>
</li>
<li>
<p>Once target reached - furtehr TSH in 3-4mo</p>
</li>
<li>
<p>annual TSH once stable</p>
<ul>
<li>unless pregnant</li>
</ul>
</li>
<li>
<p>if dose change</p>
<ul>
<li>6-8wks</li>
</ul>
</li>
<li>
<p>active ingredient same across all brands but absorption may be different</p>
<ul>
<li>if switch brand - repeat 6 weeks</li>
</ul>
</li>
<li>
<p>calcium, iron, aluminum hydroxide (antacids) and cholestyramine reduce absoprtion of levothyroine</p>
<ul>
<li>take 4 hours apart</li>
</ul>
</li>
<li>
<p>max absorption - take on empty stomach before breakfast</p>
</li>
<li>
<p>long half life = 7d</p>
</li>
<li>
<p>anticonvulsants and oestrogen therapy</p>
<ul>
<li>increase levothyroxine requirments</li>
</ul>
</li>
<li>
<p><strong>TSH </strong> = most appropriate test for monitoring hypothyroidism</p>
</li>
</ul>
</li>
</ul>
<h5 id="referal">Referal</h5>
<ul>
<li>
<p>TSH persistently above normal range</p>
<ul>
<li>
<p>check compliance</p>
</li>
<li>
<p>drug interactions</p>
</li>
<li>
<p>coeliac disease</p>
</li>
</ul>
</li>
<li>
<p>symptoms don’t respond or woresen after treatment</p>
</li>
<li>
<p>pregnant/postpartum</p>
</li>
<li>
<p>children \&lt;16yo</p>
</li>
<li>
<p>patients with co-morbidities</p>
<ul>
<li>unstable ischaemic heart disease</li>
</ul>
</li>
</ul>
<h4 id="subclinical-hypothyroidism">Subclinical hypothyroidism</h4>
<ul>
<li>
<p>increase TSH</p>
</li>
<li>
<p>noraml FT4</p>
</li>
<li>
<p>may develp hypothyroidism</p>
</li>
</ul>
<h5 id="treatment_1">Treatment</h5>
<ul>
<li>
<p>TSH \&lt;10</p>
<ul>
<li>
<p>may be considered if symptoms</p>
</li>
<li>
<p>or rising TSH or those who have goitre</p>
</li>
<li>
<p>treat for 3mo to assess symptomatic benefit</p>
</li>
<li>
<p>if not treated then monitor q6-12mo or if symptoms</p>
</li>
</ul>
</li>
<li>
<p>autoimmune Hashimoto’s thyroiditis = common cause</p>
<ul>
<li>if TSH >7 and antiTPO + then consider treatment</li>
</ul>
</li>
<li>
<p>persistently >10</p>
<ul>
<li>consider treatment</li>
</ul>
</li>
</ul>
<h3 id="hyperthyroidism">Hyperthyroidism</h3>
<h4 id="suspicion_1">suspicion</h4>
<ul>
<li>
<p>high</p>
<ul>
<li>
<p>goitre</p>
</li>
<li>
<p>thyroid bruit</p>
</li>
<li>
<p>lid lag</p>
</li>
<li>
<p>proptosis</p>
</li>
</ul>
</li>
<li>
<p>intermediate</p>
<ul>
<li>
<p>fatigue</p>
</li>
<li>
<p>weight loss</p>
</li>
<li>
<p>heat intolerance/sweating</p>
</li>
<li>
<p>fine tremor</p>
</li>
<li>
<p>increase bowel movements</p>
</li>
<li>
<p>fast heart rate/palpitaitons</p>
</li>
<li>
<p>staring gaze</p>
</li>
</ul>
</li>
<li>
<p>low</p>
<ul>
<li>
<p>nervousness</p>
</li>
<li>
<p>insomnia</p>
</li>
<li>
<p>breathlessness</p>
</li>
<li>
<p>light/absent menstrual periods</p>
</li>
<li>
<p>muscle weakness</p>
</li>
<li>
<p>warm moist skin</p>
</li>
<li>
<p>hair loss</p>
</li>
</ul>
</li>
</ul>
<h4 id="overt-hyperthryoidism">Overt hyperthryoidism</h4>
<ul>
<li>
<p>decrease TSH</p>
</li>
<li>
<p>fT4 and /or FT3 above normal range</p>
</li>
<li>
<p>complications</p>
<ul>
<li>
<p>graves’ opthalmopathy</p>
</li>
<li>
<p>thyrotoxic crisis</p>
</li>
<li>
<p>AF</p>
</li>
<li>
<p>loss of bone mass</p>
</li>
<li>
<p>CHF</p>
</li>
</ul>
</li>
<li>
<p>causes:</p>
<ul>
<li>
<p>Graves’ disease</p>
<ul>
<li>20-40yo</li>
</ul>
</li>
<li>
<p>toxic nodular goitre</p>
<ul>
<li>prevalence increase with age</li>
</ul>
</li>
<li>
<p>Thyroiditis</p>
<ul>
<li>
<p>post partum women</p>
</li>
<li>
<p>viral - type symptoms + neck pain</p>
<ul>
<li>subacute thyroiditis</li>
</ul>
</li>
</ul>
</li>
</ul>
</li>
</ul>
<h5 id="treatment_2">Treatment</h5>
<ul>
<li>
<p><strong>Carbimazole</strong> (thionamide)</p>
<ul>
<li>
<p>first episode of Graves’</p>
</li>
<li>
<p>not indicated for thyroiditis where no excessive production of thyroid hormone</p>
</li>
<li>
<p>decrease thyroid hormone synthesis</p>
<ul>
<li>interferes with organification of iodine (oxidation and binding)</li>
</ul>
</li>
<li>
<p>can be started in primary care</p>
</li>
<li>
<p><strong>15-40mg</strong> od until euthyroid</p>
<ul>
<li>4-8wks</li>
</ul>
</li>
<li>
<p>maintence = 5-15mg</p>
</li>
<li>
<p>block and replace used where high doses are used in combination with levothyroxine</p>
</li>
<li>
<p>prolonged use for 12-18mo provides best chance of sustained remission</p>
</li>
<li>
<p>relapse approx 50%</p>
<ul>
<li>
<p>smokers</p>
</li>
<li>
<p>large goitres</p>
</li>
<li>
<p>suppressed TSH at end of therapy</p>
</li>
</ul>
</li>
<li>
<p><strong>monitoring</strong></p>
<ul>
<li>TSH q4wks using FT4 and TSH until TSH normal then q2mo</li>
</ul>
</li>
<li>
<p>Adverse effects</p>
<ul>
<li>
<p>rash, fever, GI 5%</p>
</li>
<li>
<p>Bone marrow suppression = agranulocytosis = 0.1-0.5%</p>
<ul>
<li>
<p>stop and see doctor if fever, sore throat, other infections</p>
<ul>
<li>
<p>urgent FBC</p>
<ul>
<li>neutropenia</li>
</ul>
</li>
</ul>
</li>
<li>
<p>routine monitoring not recommended</p>
</li>
<li>
<p>affix to label:</p>
<ul>
<li><em>”report fever, sore throat or infection to doctor</em></li>
</ul>
</li>
</ul>
</li>
</ul>
</li>
</ul>
</li>
<li>
<p><strong>Betablockers</strong> </p>
<ul>
<li>
<p>propranolol</p>
</li>
<li>
<p>rapid relief of adrenergic symptoms</p>
<ul>
<li>
<p>tachycarida</p>
</li>
<li>
<p>tremor</p>
</li>
<li>
<p>heat intolerance</p>
</li>
<li>
<p>anxiety</p>
</li>
</ul>
</li>
</ul>
</li>
<li>
<p>radioactive iodine/surgery</p>
<ul>
<li>
<p>relapses</p>
</li>
<li>
<p>may be appropriate first choice treatment for toxic nodular goitre</p>
</li>
<li></li>
</ul>
</li>
</ul>
<h4 id="subclincial-hyperthroidism">Subclincial hyperthroidism</h4>
<ul>
<li>
<p>TSH low</p>
</li>
<li>
<p>FT4/3 normal</p>
</li>
<li>
<p>causes</p>
<ul>
<li>
<p>excessive levothyroxine replacement</p>
</li>
<li>
<p>autonomously functioning multi-nodular goitre</p>
</li>
<li>
<p>subclinical Graves’ disease</p>
</li>
</ul>
</li>
<li>
<p>increased risk of AF</p>
<ul>
<li>possibly osteoporosis</li>
</ul>
</li>
<li>
<p>if undetectable TSH then consider treatment</p>
</li>
</ul>
<h3 id="pregnancy">Pregnancy</h3>
<h4 id="hypothryoidism">Hypothryoidism</h4>
<ul>
<li>
<p>Screening not routinely recommeneded</p>
<ul>
<li>subclinical hypothyroidism associatedwith ovulatory dysfucntion and infertility</li>
</ul>
</li>
<li>
<p>Thryoid testing</p>
<ul>
<li>
<p>symptoms</p>
</li>
<li>
<p>increase risk</p>
<ul>
<li>
<p>T1DM</p>
</li>
<li>
<p>personal or FHx</p>
</li>
</ul>
</li>
</ul>
</li>
<li>
<p>TSH temporarily decrease first trimester</p>
<ul>
<li>
<p>Thyriod stimulating effects of hCG</p>
</li>
<li>
<p>FT4 tends to fall slowly in second half of pregnancy</p>
</li>
</ul>
</li>
<li>
<p>Aim</p>
<ul>
<li>normalise both TSH and FT4</li>
</ul>
</li>
<li>
<p>majority need dose increase</p>
<ul>
<li>
<p>usually during first 1/3</p>
<ul>
<li>
<p>proactive increase 30% once pregnancy confirmed</p>
<ul>
<li>double maintenece on 2 days/week</li>
</ul>
</li>
<li>
<p>Dose requirement stabilise by 20weeks then fall back to normal</p>
</li>
<li>
<p>t4 above 10-14</p>
</li>
</ul>
</li>
</ul>
</li>
</ul>
<h4 id="hyperthyroidism_1">Hyperthyroidism</h4>
<ul>
<li>
<p>increase risk of foetal loss, pre-eclampsia, heart failure, premature labour, low birth-weight infant</p>
</li>
<li>
<p>Thionamides preferred treatment choice</p>
</li>
<li>
<p>lowest possible dose to control symptoms</p>
</li>
<li>
<p>last trimester cease anti-thryoid</p>
</li>
<li>
<p>propylthiouracil (PTU) preferred</p>
<ul>
<li>
<p>carbimazole associated with rare teratogenic effects</p>
</li>
<li>
<p>associated significant liver toxicity</p>
</li>
<li>
<p>block and replace not suitable</p>
</li>
</ul>
</li>
</ul>
<h3 id="drugs">drugs</h3>
<h4 id="amiodarone">Amiodarone</h4>
<ul>
<li>
<p>either hypo/hyper 14-18%</p>
<ul>
<li>
<p>high iodine content</p>
</li>
<li>
<p>direct toxic effect on thyroid</p>
</li>
</ul>
</li>
<li>
<p>initial rise in TSH will return to nroaml within 3mo</p>
</li>
<li>
<p>inbhibits peripheral conversion of T4-T3</p>
</li>
<li>
<p>TSH best marker</p>
</li>
<li>
<p>baseline then 6 monthly</p>
</li>
<li>
<p>monitoring 12mo after cesastion may be required</p>
</li>
</ul>
<h4 id="lithium">Lithium</h4>
<ul>
<li>
<p>hypothyroidism common</p>
</li>
<li>
<p>appear abruptly even after long-term treatment</p>
</li>
<li>
<p>Femalses and people with + TPO antibodies are at increase risk</p>
</li>
<li>
<p>Lithium-associated hyperthyroidism rare</p>
</li>
<li>
<p>TSH and FT4 @ baseline</p>
</li>
<li>
<p>TSH @ 3 months</p>
</li>
<li>
<p>then yearly</p>
</li>
<li></li>
</ul>
<p>end</p>
      </div>
    </div>

  </div>
    

    <div class="footer">
        <p>Website powered by <a href="http://urubu.jandecaluwe.com">Urubu</a></p>
    </div>


</div> 


    <!-- jQuery (necessary for Bootstrap's JavaScript plugins) -->
    <script src="https://code.jquery.com/jquery.js"></script>
    <!-- Include all compiled plugins (below), or include individual files as needed -->
    <script src="//netdna.bootstrapcdn.com/bootstrap/3.2.0/js/bootstrap.min.js"></script>

  </body>
</html>
